KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Assets (2016 - 2025)

Historic Current Assets for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $507.4 million.

  • Fulgent Genetics' Current Assets rose 5537.93% to $507.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $507.4 million, marking a year-over-year increase of 5537.93%. This contributed to the annual value of $353.6 million for FY2024, which is 3037.82% down from last year.
  • Per Fulgent Genetics' latest filing, its Current Assets stood at $507.4 million for Q3 2025, which was up 5537.93% from $428.7 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Current Assets ranged from a high of $765.3 million in Q1 2022 and a low of $326.5 million during Q3 2024
  • Its 5-year average for Current Assets is $537.4 million, with a median of $549.9 million in 2023.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 168025.66% in 2021, then crashed by 4061.36% in 2024.
  • Over the past 5 years, Fulgent Genetics' Current Assets (Quarter) stood at $612.0 million in 2021, then rose by 2.6% to $627.9 million in 2022, then fell by 19.12% to $507.8 million in 2023, then crashed by 30.38% to $353.6 million in 2024, then soared by 43.5% to $507.4 million in 2025.
  • Its last three reported values are $507.4 million in Q3 2025, $428.7 million for Q2 2025, and $416.8 million during Q1 2025.